Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20200030 17.11.2022
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
BN N/2020/0030 30.10.2018
(40) Publication Number and Date
BN N/2020/0030
A
17.11.2022
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/581,967
06.11.2017
(51) IPC Classes
(72) Inventor
(EN) HENRY, Kenneth James, JR.
(EN) KHILEVICH, Albert
(EN) KUKLISH, Steven, Lee
(EN) PARTRIDGE, Katherine, Marie
(74) Representative Name
(EN) M/S Spruson & ferguson : C/O Ahmad Isa& Partners Unit 404A-410A 4th Floor, Wisma Jaya Jalan Pemancha Bandar Seri Begawan BS8811
(54) Title
(EN) BTK INHIBITOR COMPOUNDS
(57) Abstract
(EN)

The invention provides BTK Inhibitor compounds, pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat autoimmune diseases such as Rheumatoid Arthritis.

(58) Citations
Document Type Date Action
Event NameDateStatus
Filing30.10.2018Filed
PCT National Phase Entry15.04.2020PCT National Phase
Registration17.11.2022Registered
Publication17.11.2022Published